Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

16

Revenue 2017

Shire

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Shire's 2013 CNS, immunology and metabolic's sales performance.

Shire

Takeda highlights 12 NMEs with $10bn-plus sales potential at R&D day

Takeda highlights 12 NMEs with $10bn-plus sales potential at R&D day

Just under a year after closing its $62bn acquisition of Shire, Takeda has laid out the highlights of its new pipeline, pointing to 12 new drugs with the potential to launch

Takeda divests over-the-counter and prescription drugs to Stada for $660m

Takeda divests over-the-counter and prescription drugs to Stada for $660m focus on its five key business areas and takeover of Irish biotech Shire. ... In addition to focusing on its key growth areas, Takeda is completing the divestments to accelerate its acquisition of Shire, which it announced in  2018.

Takeda offloads select portfolio to Acino ahead of Shire takeover

Takeda offloads select portfolio to Acino ahead of Shire takeover According to a statement from Takeda, it will use the cash from the deal to reduce its debts, following its takeover of Shire. ... However, Takeda maintained that Shire will help it grow outside Japan, and increase the company’s pipeline in the process.

Takeda’s HAE drug Takhzyro backed by NICE

Takeda’s HAE drug Takhzyro backed by NICE Like Firazyr and Cinryze, Takhzyro was originally developed by Shire, which has been absorbed by Takeda in a  $63bn takeover.

Takeda makes Crohn’s disease case for subcutaneous Entyvio

Takeda makes Crohn’s disease case for subcutaneous Entyvio Patent expiries and a weak near-term pipeline were the main drivers for Takeda's  $63bn takeover of Shire, which completed in January.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

Pharma index map
The 2019 CPhI Pharma Index Report
Examining this year’s industry performance...
Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...

Infographics